1.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 12154, NCT01438112
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003/081/HP, NCT00213655
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: 102.1, NCT00384891
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: EMBARK, NCT01082510
|
|
5.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CRC-TU-BL3010-HYMN, CRCTU-BL3010-HYMN, ISRCTN85785327, EUDRACT-2008-005428-99, EU-21015, UCL-08/0365, KYOWA-CRC-TU-BL3010-HYMN, MREC-09/H0717/56, NCT01094964
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: 20 to 80 Sponsor: Other Protocol IDs: CMC-11-0015-CTIL, NCT01542567
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: Sutent V5 / November 9, 2009, NCT00794950
|
|
8.
|
Phase: No phase specified Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 14585, NCT01240824
|